FAKTOR OPTIONSSCHEIN - MERCK & CO. | Delayed Deutsche Boerse AG 11:08:51 15/05/2024 pm IST | ||
| 0.92 EUR | -14.81% |
|
| Current month | +5.88% | ||
| 1 month | -17.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 15/24/15 | 0.92 | -14.81% |
| 14/24/14 | 1.08 | 0.00% |
| 13/24/13 | 1.08 | +9.09% |
| 10/24/10 | 0.99 | -1.00% |
| 09/24/09 | 1 | -2.91% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 11:08 pm IST
More quotesStatic data
| Product type | Warrant Esotici e Strutturati |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UL5PY2 |
| ISIN | DE000UL5PY24 |
| Date issued | 14/07/2023 |
| Strike | 150.1 $ |
| Maturity | Unlimited |
| Parity | 18.43 : 1 |
| Emission price | 5.31 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.49 € |
|---|---|
| Lowest since issue | 0.9 € |
| Spread | 0.03 € |
| Spread % | 3.13% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7
USD
Average target price
141.6
USD
Spread / Average Target
+10.09%
- Stock Market
- Certificates
- Certificat